Literature DB >> 9008222

Ultraviolet A irradiation upregulates type VII collagen expression in human dermal fibroblasts.

M Chen1, M J Petersen, H L Li, X Y Cai, E A O'Toole, D T Woodley.   

Abstract

Type VII collagen, a major component of skin-anchoring fibrils, is synthesized by both fibroblasts and keratinocytes, the two principal cell types in the skin. In this study, we examined the effects of ultraviolet A (UVA) irradiation on the expression of type VII collagen in human fibroblasts. UVA irradiation (0-15 J/cm2) caused a dose-dependent increase (5- to 10-fold) in type VII collagen mRNA levels as detected by northern blot analysis. The UVA-induced enhancement of type VII collagen gene expression correlated with an increase in its protein level by immunoblot analysis of proteins secreted into the conditioned medium. The effect of UVA was observed at 12 h and reached its maximum by 18 h. Under these conditions, however, the expression of fibronectin, a major dermal matrix protein, remained unchanged, suggesting that the induction of type VII collagen expression was selective. Actinomycin D, a transcription inhibitor, blocked the UVA-mediated induction of type VII collagen gene expression, whereas cycloheximide, a protein synthesis inhibitor, superinduced the expression of type VII collagen, suggesting that de novo protein synthesis was not required for the action of UVA. Interestingly, in contrast to the increased type VII collagen expression in fibroblasts in response to UVA, a slight decrease in type VII collagen mRNA level was observed in the UVA-irradiated keratinocytes, suggesting that the effect of UVA on the type VII collagen expression is cell type specific.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008222     DOI: 10.1111/1523-1747.ep12332300

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas.

Authors:  P Dehan; D Waltregny; A Beschin; A Noel; V Castronovo; K Tryggvason; J De Leval; J M Foidart
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice.

Authors:  Yingping Hou; Lin T Guey; Timothy Wu; Robert Gao; Jon Cogan; Xinyi Wang; Elizabeth Hong; Weihuang Vivian Ning; Douglas Keene; Nan Liu; Yan Huang; Craig Kaftan; Bruce Tangarone; Igor Quinones-Garcia; Jouni Uitto; Omar L Francone; David T Woodley; Mei Chen
Journal:  J Invest Dermatol       Date:  2015-07-23       Impact factor: 8.551

3.  Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis.

Authors:  David T Woodley; Yingping Hou; Sabrina Martin; Wei Li; Mei Chen
Journal:  J Biol Chem       Date:  2008-04-30       Impact factor: 5.157

4.  Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure.

Authors:  Xinyi Wang; Pedram Ghasri; Mahsa Amir; Brian Hwang; Yingpin Hou; Michael Khalili; Michael Khilili; Andrew Lin; Douglas Keene; Jouni Uitto; David T Woodley; Mei Chen
Journal:  Mol Ther       Date:  2013-05-14       Impact factor: 11.454

5.  Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.

Authors:  Jennifer Remington; Xinyi Wang; Yingpin Hou; Hui Zhou; Julie Burnett; Trevor Muirhead; Jouni Uitto; Douglas R Keene; David T Woodley; Mei Chen
Journal:  Mol Ther       Date:  2008-11-18       Impact factor: 11.454

6.  Fludarabine modulates expression of type VII collagen during haematopoietic stem cell transplantation for recessive dystrophic epidermolysis bullosa.

Authors:  M Vanden Oever; D Muldoon; W Mathews; J Tolar
Journal:  Br J Dermatol       Date:  2021-03-08       Impact factor: 11.113

7.  De novo anti-type VII collagen antibodies in patients with recessive dystrophic epidermolysis bullosa.

Authors:  David T Woodley; Jon Cogan; Xinyi Wang; Yingping Hou; Cyrus Haghighian; Gail Kudo; Douglas R Keene; Mei Chen
Journal:  J Invest Dermatol       Date:  2013-11-08       Impact factor: 8.551

8.  A Novel Fully Humanized 3D Skin Equivalent to Model Early Melanoma Invasion.

Authors:  David S Hill; Neil D P Robinson; Matthew P Caley; Mei Chen; Edel A O'Toole; Jane L Armstrong; Stefan Przyborski; Penny E Lovat
Journal:  Mol Cancer Ther       Date:  2015-09-01       Impact factor: 6.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.